Self-Experimentation in the Time of COVID-19
Self-Experimentation in the Time of COVID-19
Scientists are taking their own vaccines, an ethically murky practice that has a long and sometimes celebrated history in medicine.
Self-Experimentation in the Time of COVID-19
Self-Experimentation in the Time of COVID-19

Scientists are taking their own vaccines, an ethically murky practice that has a long and sometimes celebrated history in medicine.

Scientists are taking their own vaccines, an ethically murky practice that has a long and sometimes celebrated history in medicine.

vaccines
Extreme Biotech: Understanding Extremophile Biology to Impact Human Health
Extreme Biotech: Understanding Extremophile Biology to Impact Human Health
The Scientist Creative Services Team | Aug 6, 2020
Jaclyn Winter and Shiladitya DasSarma will discuss how they harness the unique biology of extremophiles for the discovery and development of new therapeutics.
Flu and Pneumonia Vaccines Linked to Reduced Risk of Alzheimer’s
Flu and Pneumonia Vaccines Linked to Reduced Risk of Alzheimer’s
Amanda Heidt | Jul 27, 2020
The authors propose that the shots might keep the immune system primed to battle diseases that would otherwise contribute to cognitive decline.
Coronavirus Vaccine Data Are Targets for Foreign Hackers
Coronavirus Vaccine Data Are Targets for Foreign Hackers
Amanda Heidt | Jul 17, 2020
Intelligence officials from the US, UK, and Canada point the finger at Cozy Bear, a group with links to the Russian government.
Infographic: Mix and Match
Infographic: Mix and Match
Ruth Williams | Jul 13, 2020
How llamas and superglue might lead to antiviral therapies
Improving COVID-19 Treatment & Vaccine Development by Modulating the Immune Response: Applying Single-Cell Proteomics 
Improving COVID-19 Treatment & Vaccine Development by Modulating the Immune Response: Applying Single-Cell Proteomics 
The Scientist Creative Services Team | Jun 10, 2020
James R. Heath, PhD, President of the Institute for Systems Biology will discuss key single-cell learnings and applications from the large Seattle-based academic pharmaceutical consortium committed to defining molecular mechanisms of SARS-CoV-2 infection and identifying potential prognostic immune biomarkers. Stacey Willard, PhD, from IsoPlexis will discuss how functional phenotyping individual immune cells using IsoPlexis technology edges researchers closer to predicting the risk for severe disease. 
Infographic: Vaccines on Film
Infographic: Vaccines on Film
Ruth Williams | Jun 1, 2020
How an experimental preparation technique could make vaccines easier to transport, store, and administer
Vaccines Without Vials, Fridges, or Needles
Vaccines Without Vials, Fridges, or Needles
Ruth Williams | Jun 1, 2020
A novel preparation technique could facilitate vaccine preservation, transportation, and administration.
Support for Vaccine Challenge Trials Gains Momentum
Support for Vaccine Challenge Trials Gains Momentum
Shawna Williams | May 11, 2020
The idea of deliberately infecting volunteers with SARS-CoV-2 has garnered significant attention as a potential avenue to speedier development, as the World Health Organization weighs in with recommendations.
Bioethicists Criticize WHO’s Malaria Vaccine Trial
Bioethicists Criticize WHO’s Malaria Vaccine Trial
Lisa Winter | Feb 28, 2020
The study, conducted in Malawi, Kenya, and Ghana, did not obtain informed consent from each parent whose child participated, but rather considered consent “implied” because of the particular experimental design.